Learn / Stock guides / ABBV vs GILD
CompareAbbVie vs Gilead Sciences: how do the stocks compare?
ABBV and GILD side by side, in plain English. This is an explanation of the two businesses, not a recommendation to buy either one.
| ABBV | GILD | |
|---|---|---|
| Ticker | ABBV | GILD |
| Exchange | NYSE | NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers General | Drug Manufacturers General |
| Size | mega cap | large cap |
| Market value | 464.3 billion dollars | 179.5 billion dollars |
AbbVie (ABBV)
AbbVie trades on the New York Stock Exchange under the ticker ABBV. It is a mega cap company in the drug manufacturers general industry, part of the healthcare sector, with a market value of about 464.3 billion dollars.
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
Gilead Sciences (GILD)
Gilead Sciences trades on the Nasdaq under the ticker GILD. It is a large cap company in the drug manufacturers general industry, part of the healthcare sector, with a market value of about 179.5 billion dollars.
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
Follow ABBV and GILD every day
Add both to your watchlist and read a free plain English brief every trading day at 5 PM ET.
Start my free briefCommon questions
What is the difference between ABBV and GILD?
AbbVie trades on the New York Stock Exchange under the ticker ABBV. It is a mega cap company in the drug manufacturers general industry, part of the healthcare sector, with a market value of about 464.3 billion dollars. Gilead Sciences trades on the Nasdaq under the ticker GILD. It is a large cap company in the drug manufacturers general industry, part of the healthcare sector, with a market value of about 179.5 billion dollars.
Which is bigger, AbbVie or Gilead Sciences?
AbbVie has the larger market value, at about 464.3 billion dollars.
Are AbbVie and Gilead Sciences in the same industry?
Yes. Both are in the drug manufacturers general industry.
Educational information, not financial advice. Figures are approximate and do not include live prices.